Who is sponsoring NCT05433935?

NCT05433935 is sponsored by Zhejiang University.

What drugs are being tested in NCT05433935?

Interventions in NCT05433935: Observation.

What condition does NCT05433935 study?

NCT05433935 studies Intraductal Papillary Mucinous Neoplasm.

Is NCT05433935 still recruiting?

NCT05433935 is currently recruiting now. Last updated 27 January 2023.

Last reviewed 2023-01-27 · How we verify

NCT05433935

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

Recruiting now Last updated 27 January 2023

What this trial tests

trial testing Observation in Intraductal Papillary Mucinous Neoplasm in 5,000 participants. Currently enrolling.

Timeline

1 July 2022

Primary endpoint
30 June 2032

31 December 2033

Quick facts

Lead sponsor	Zhejiang University
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	5,000
Start date	1 July 2022
Primary completion	30 June 2032
Estimated completion	31 December 2033
Sites	1 location across China

Drugs / interventions tested

Observation

Conditions studied

Intraductal Papillary Mucinous Neoplasm — all drugs for Intraductal Papillary Mucinous Neoplasm →

Sponsor

Zhejiang University

Who can join

Adults 0 to 90, any sex, with Intraductal Papillary Mucinous Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, open large cohort study to explore biomarkers for detecting early carcinogenesis of IPMN.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Observation

Trials testing the same drug.

NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
NCT07563088 — SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · not yet recruiting
NCT07513324 — Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · Phase 2 · not yet recruiting
NCT07457099 — Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral a · not yet recruiting
NCT07472478 — Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12 · Phase 2 · not yet recruiting

Other recruiting trials for Intraductal Papillary Mucinous Neoplasm

Currently open trials in the same condition.

NCT07117045 — Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer · recruiting
NCT06638866 — AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort · recruiting
NCT04291651 — UCSF PANC Cyst Registry · recruiting

Other Zhejiang University trials

Trials by the same sponsor.

NCT07487402 — Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurr · EARLY_PHASE1 · not yet recruiting
NCT07480044 — A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly · NA · not yet recruiting
NCT07467005 — Video Double-Lumen Tube for Secondary Pulmonary Resection · NA · not yet recruiting
NCT07429461 — Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia · EARLY_PHASE1 · recruiting
NCT07240766 — HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05433935 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zhejiang University
Last refreshed: 27 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05433935.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing